Express Scripts, CVS Face ERISA Suit Over EpiPen Costs
By Dani Kass · June 5, 2017, 6:16 PM EDT
Express Scripts, CVS Health and Prime Therapeutics on Friday were drawn into the conflict over how EpiPens became so expensive after a potential class of patients accused the pharmacy benefit managers...
To view the full article, register now.